Gastrointestinal Cancer | Specialty

The OncLive Gastrointestinal Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of gastrointestinal (GI) cancers, including hepatocellular carcinoma, gastric cancer, pancreatic cancer, colorectal cancer, cholangiocarcinoma, esophageal cancer, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in GI cancers.

Improving Responsiveness With Immunotherapy in mCRC

March 29th 2019

Dosing Strategies and Patient Support in mCRC

March 29th 2019

Optimizing Dosing in Patients With mCRC

March 29th 2019

Adjusting the Lines of Therapy Indication in mCRC

March 29th 2019

Puzzling Together the Pieces in mCRC

March 29th 2019

The Influx of Younger Patients With Advanced CRC

March 29th 2019

Sequencing for BRAF+, RAS+, HER2- Left-Sided CRC

March 29th 2019

Multidisciplinary Approach to Resection in mCRC

March 29th 2019

Tissue-Based Testing Versus Liquid Biopsy in mCRC

March 29th 2019

Considering the Basics in Newly Diagnosed mCRC

March 29th 2019

Molecular Markers Gaining Greater Influence in CRC Paradigm

March 27th 2019

Mohamed E. Salem, MD, highlights ongoing research efforts to potentially improve survival in patients with metastatic colorectal cancer.

Testing, Treatment Options Added to NCCN CRC Guidelines

March 25th 2019

A theme of the 2019 NCCN Annual Conference was the expansion of biomarker testing to guide treatment, and a review of brand-new changes for guidelines in colorectal cancer was no different.

Germline Testing Emphasized in NCCN Guidelines on Pancreatic Cancer

March 22nd 2019

In recent years, pancreatic has passed breast cancer as the third leading cause of cancer death in the United States, and by 2030 it could be the leading cause.

Hepatocellular Carcinoma's Future Treatment Paradigm

March 22nd 2019

Ramucirumab's Role in Managing HCC

March 22nd 2019

Considering Adverse Events in Hepatocellular Carcinoma

March 22nd 2019

Sequencing Agents in HCC Based on Patient Subgroups

March 22nd 2019

Approaching Sequencing in HCC: Second-Line Therapy

March 22nd 2019

Frontline Therapy for HCC: Optimizing Treatment Selection

March 22nd 2019

Hepatocellular Carcinoma: Switching to Systemic Therapy

March 22nd 2019